OTC:AXIM | Free Cash Flow | AXIM BIOTECHNOLOGIES, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-03-31 to 2024-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2024-03-31-$1.07M$2,839.00-$1.07M
2023-12-31$19,556.00$0.00$19,556.00
2023-03-31-$141,959.00
2022-12-31-$315,505.00$0.00-$315,505.00
2022-03-31-$703,717.00
2021-12-31-$792,932.00
2021-03-31-$565,461.00
2019-03-31-$728,549.00
2018-12-31-$1.04M
2018-03-31-$1.16M
2017-12-31-$1.02M
2017-03-31-$580,922.00
2016-12-31-$532,447.00$0.00-$532,447.00
2016-03-31-$193,201.00
2015-12-31-$418,804.00-$33,581.00-$452,385.00
2015-03-31-$465,874.00
2014-12-31-$288,682.00$0.00-$288,682.00
2014-03-31-$127.00
2013-12-31-$3,703.00
2013-03-31-$4,700.00
2012-12-31$11,246.00
2012-03-31$6,490.00
2011-12-31$4,050.00
2011-03-31$0.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2023-12-31-$1.03M$0.00-$1.03M
2022-12-31-$2.04M$8,710.00-$2.05M
2021-12-31-$2.49M$40,495.00-$2.53M
2018-12-31-$4.85M
2017-12-31-$3.08M
2016-12-31-$1.29M$0.00-$1.29M
2015-12-31-$1.54M-$16,780.00-$1.56M
2014-12-31-$338,999.00$0.00-$338,999.00
2013-12-31-$33,018.00
2012-12-31$21,105.00
2011-12-31$4,038.00